RGS14 is a multifunctional scaffolding protein possessing two distinct G protein interaction sites including a regulator of G protein signaling (RGS) domain that acts as a GTPase activating protein (GAP) to deactivate Gi/o-GTP proteins, and a G protein regulatory (GPR) motif that binds inactive Gi1/3-GDP proteins independent of G. GPR interactions with Gi recruit RGS14 to the plasma membrane to interact with Gi-linked GPCRs and regulate Gi signaling. While RGS14 actions on G proteins are well characterized, consequent effects on G signaling remain unknown. Conventional RGS proteins act as dedicated GAPs to deactivate G and G signaling following receptor activation. RGS14 may do the same or, alternatively, may coordinate its actions to deactivate G-GTP with the RGS domain and then capture the same G-GDP via its GPR motif to prevent heterotrimer reassociation and prolong G signaling. To test this idea, we compared the regulation of G protein activation and deactivation kinetics by a conventional RGS protein, RGS4, and RGS14 in response to GPCR agonist/antagonist treatment utilizing bioluminescence resonance energy transfer (BRET). Co-expression of either RGS4 or RGS14 inhibited the release of free G after agonist stimulation and increased the deactivation rate of G, consistent with their roles as GTPase activating proteins (GAPs). Overexpression of inactive Gi1 to recruit RGS14 to the plasma membrane did not alter RGS14's capacity to act as a GAP for a second Go protein. These results demonstrate the role of RGS14 as a dedicated GAP and suggest that the G protein regulatory (GPR) motif functions independently of the RGS domain and is silent in regulating GAP activity in a cellular context.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045935 | PMC |
http://dx.doi.org/10.1002/prp2.249 | DOI Listing |
Am J Med Genet A
November 2024
The Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Here we describe a neonate exhibiting hypotonia, macrocephaly, renal cysts, and respiratory failure requiring tracheostomy and ventilator support. Genetic analysis via rapid genome sequencing (rGS) identified a loss on chromosome 4 encompassing polycystin-2 (PKD2) and a loss on chromosome 22 encompassing SH3 and Multiple Ankyrin Repeat Domains 3 (SHANK3), indicative of Phelan-McDermid syndrome. Further analysis via traditional karyotyping, Optical Genome Mapping (OGM), and PacBio long-read sequencing revealed a more complex landscape of chromosomal rearrangements in this individual, including a balanced 3;12 translocation, and an unbalanced 17;22 translocation.
View Article and Find Full Text PDFInt J Mol Sci
October 2024
Department of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Bipolar disorder's etiology involves genetics, environmental factors, and gene-environment interactions, underlying its heterogeneous nature and treatment complexity. In 2020, Forstner and colleagues catalogued 378 sequence variants co-segregating with familial bipolar disorder. A notable candidate was an R59Q missense mutation in the PDZ (PSD-95/Dlg1/ZO-1) domain of RGS12.
View Article and Find Full Text PDFMil Med Res
October 2024
Department of Urology, University College Hospital of London, London, NW1 2BU, UK.
J Thromb Haemost
October 2024
National Institute of Health and Medical Research, National Research Institute for Agriculture, Food and Environment, Research Center for Cardiovascular and Nutrition, Faculty of Medicine, Aix Marseille University, Marseille, France; Reference Center on Constitutional Platelet Disorders, Biogenopole, University Hospital Center Timone, Public Assistance - Hospitals of Marseille, Marseille, France. Electronic address:
Background: Inherited platelet diseases are bleeding disorders characterized by either defects in platelet count or platelet function, the latter being less common and very heterogeneous. Numerous gene variants associated with abnormal receptors, granules, and signaling pathways have been reported. Despite significant advancements in our understanding, many patients still lack a precise diagnosis.
View Article and Find Full Text PDFSignal Transduct Target Ther
October 2024
Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!